Top

Published in:

Open Access 01-12-2015 | Case Report

Pancreatic mucinous cystic neoplasm in a transgender patient

Authors: Deshka Foster, Mohammad F. Shaikh, Elizabeth Gleeson, Blake D. Babcock, Jianping Lin, Robert T. Ownbey, Mark E. Hysell, Daniel Ringold, Wilbur B. Bowne

Published in: World Journal of Surgical Oncology | Issue 1/2015

Abstract

Background

Cystic pancreatic lesions are increasingly more frequent detected clinical entities. Mucinous cystic neoplasm (MCN) is a hormone-related pancreatic tumor (HRTP) with a strong predominance in young and middle-aged females.

Case presentation

Here, we present the case of a 31-year-old surgically transgendered female-to-male patient with a history of alcoholic pancreatitis, on chronic testosterone therapy. He was found to have a pancreatic MCN and underwent distal pancreatectomy and splenectomy.

Conclusion

To our knowledge, this is the first reported case of a transgender patient with a history of hormone replacement therapy (HRT) and pancreatic MCN. We consider possible mechanisms for the pathogenesis to explain this patient’s neoplasm.

Wouters K, Ectors N, Van Steenbergen W, Aerts R, Driessen A, Van Hoe L, et al. A pancreatic mucinous cystadenoma in a man with mesenchymal stroma, expressing oestrogen and progesterone receptors. Virchows Arch. 1998;432(2):187–9.PubMedCrossRef

Goh BKP, Tan Y-M, Chung Y-FA, Chow PKH, Cheow P-C, Wong W-K, et al. A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients. World J Surg. 2006;30:2236–45.PubMedCrossRef

Allen PJ, D’Angelica M, Gonen M, Jaques DP, Coit DG, Jarnagin WR, et al. A selective approach to the resection of cystic lesions of the pancreas. Ann Surg. 2006;244:572–82.PubMedCentralPubMed

Allen PJ, Jaques DP, D’Angelica M, Bowne WB, Conlon KC, Brennan MF. Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients. J Gastrointest Surg. 2003;7:970–7.PubMedCrossRef

Andrén-Sandberg A, Hoem D, Bäckman PL. Other risk factors for pancreatic cancer: hormonal aspects. Ann Oncol. 1999;10 Suppl 4:131–5.PubMedCrossRef

Herring AA, Graubard MB, Gan SI, Schwaitzberg SD. Mucinous cystadenocarcinoma of the pancreas during pregnancy. Pancreas. 2007;34:470–3.PubMedCrossRef

Ikuta S. Large mucinous cystic neoplasm of the pancreas associated with pregnancy. World J Gastroenterol. 2008;14:7252.PubMedCentralPubMedCrossRef

Ishikawa K, Hirashita T, Kinoshita H, Kitano M, Matsuo S, Matsumata T, et al. Large mucinous cystadenoma of the pancreas during pregnancy: report of a case. Surg Today. 2007;37:1013–7.PubMedCrossRef

Kato M, Kubota K, Kita J, Shimoda M, Rokkaku K, Inaba N, et al. Huge mucinous cystadenoma of the pancreas developing during pregnancy: a case report. Pancreas. 2005;30:186–8.PubMedCrossRef

10.

Smithers BM, Welch C, Goodall P. Cystadenocarcinoma of the pancreas presenting in pregnancy. Br J Surg. 1986;73:591.PubMedCrossRef

11.

Tanaka S, Kawamura T, Nakamura N, Teramoto K, Arii S. Mucinous cystadenocarcinoma of the pancreas developing during hormone replacement therapy. Dig Dis Sci. 2007;52:1326–8.PubMedCrossRef

12.

Suzuki M, Fujita N, Onodera H, Kayaba Y, Suzuki S, Kagaya H, et al. Mucinous cystic neoplasm in a young male patient. J Gastroenterol. 2005;40:1070–4.PubMedCrossRef

13.

Regi P, Salvia R, Cena C, Girelli R, Frigerio I, Bassi C. Cystic “feminine” pancreatic neoplasms in men. Do any clinical alterations correlate with these uncommon entities? Int J Surg. 2013;11:157–60.PubMedCrossRef

14.

Turo R, Jallad S, Prescott S, Cross WR. Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy. Can Urol Assoc J. 2013;7(7–8):E544–6.PubMedCentralPubMed

15.

Miksad RA, Bubley G, Church P, Sanda M, Rofsky N, Kaplan I, et al. Prostate cancer in a transgender woman 41 years after initiation of feminization. JAMA. 2006;296:2316–7.PubMedCrossRef

16.

Zamboni G, Scarpa A, Bogina G, Iacono C, Bassi C, Talamini G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol. 1999;23:410–22.PubMedCrossRef

17.

Iqbal MJ, Greenway B, Wilkinson ML, Johnson PJ, Williams R. Sex-steroid enzymes, aromatase and 5 alpha-reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue. Clin Sci (Lond). 1983;65:71–5.

Title: Pancreatic mucinous cystic neoplasm in a transgender patient
Authors: Deshka Foster
Mohammad F. Shaikh
Elizabeth Gleeson
Blake D. Babcock
Jianping Lin
Robert T. Ownbey
Mark E. Hysell
Daniel Ringold
Wilbur B. Bowne
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2015
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/s12957-015-0620-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pancreatic mucinous cystic neoplasm in a transgender patient

Abstract

Background

Case presentation

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Case presentation

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2015

Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging

The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection

Functional outcome and complications following reconstruction for Harrington class II and III periacetabular metastasis

Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors

mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer

Well-differentiated abdominal liposarcoma: experience of a tertiary care center